Longwood Founders Fund

Longwood Founders Fund

$25,000,000 Venture capital (Series B)
FinSMEs

Axial Biotherapeutics Raises $25M in Series B Financing

$30,000,000 Venture capital
FinSMEs

OvaScienceSM and Millendo Therapeutics Merge; New Company Raises $30M

Funding Strategy Science
Xconomy

At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA

Health
$14,100,000 Venture capital (Series C)
medicaldevicedaily , vcaonline

BioWorld MedTech

Xconomy

Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug

Health Science
Xconomy

Millendo Launches Phase 2b Study of PCOS Drug After Year of Growth

Health Science
$62,000,000 Venture capital (Series B)
FinSMEs

Millendo Therapeutics Raises $62M in Series B Funding

Health Funding
Xconomy

Verastem Sinks as Mesothelioma Study Halted For Futility

Health